Targeting monocytes/macrophages in the treatment of rheumatoid arthritis

被引:174
作者
Davignon, Jean-Luc [1 ,2 ,3 ,4 ]
Hayder, Myriam [1 ,2 ,3 ]
Baron, Michel [1 ,2 ,3 ]
Boyer, Jean-Frederic [1 ,2 ,3 ,4 ]
Constantin, Arnaud [4 ,5 ]
Apparailly, Florence [6 ,7 ]
Poupot, Remy [1 ,2 ,3 ]
Cantagrel, Alain [1 ,2 ,3 ,4 ]
机构
[1] INSERM, U1043, F-31400 Toulouse, France
[2] CNRS, U5282, F-31400 Toulouse, France
[3] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, F-31400 Toulouse, France
[4] Hop Purpan, Ctr Hosp Univ Toulouse, Ctr Rhumatol, F-31400 Toulouse, France
[5] INSERM, U1027, F-31400 Toulouse, France
[6] Hop St Eloi, INSERM, U844, Montpellier, France
[7] Univ Montpellier I, Montpellier, France
关键词
monocytes; RA; inflammation; novel therapies; biotherapies; targeting; TNF-alpha; siRNA; cPLA(2)alpha; dendrimer; animal models; TUMOR-NECROSIS-FACTOR; COLLAGEN-INDUCED ARTHRITIS; COLONY-STIMULATING FACTORS; TNF-ALPHA; TRANSMEMBRANE TNF; IN-VIVO; C-FMS; CITRULLINATED PROTEINS; MACROPHAGE ACTIVATION; MONOCYTE ACTIVATION;
D O I
10.1093/rheumatology/kes304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Biotherapies have revolutionized the treatment of RA. However, much work is needed to understand all the mechanisms of these biotherapies, and alternatives are needed to circumvent adverse effects and the high cost of these long-lasting treatments. In this article we outline some of the approaches we have used to target monocytes/macrophages as major components of inflammation and bone homeostasis. We also discuss how anti-TNF-alpha antibodies target monocytes/macrophages in the complex mechanisms contributing to inhibition of inflammation.
引用
收藏
页码:590 / 598
页数:9
相关论文
共 114 条
[1]   Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection [J].
Allie, Nasiema ;
Alexopoulou, Lena ;
Quesniaux, Valerie J. F. ;
Fick, Lizette ;
Kranidioti, Ksanthi ;
Kollias, George ;
Ryffel, Bernhard ;
Jacobs, Muazzam .
IMMUNOLOGY, 2008, 125 (04) :522-534
[2]   CD14 is an acute-phase protein [J].
Bas, S ;
Gauthier, BR ;
Spenato, U ;
Stingelin, S ;
Gabay, C .
JOURNAL OF IMMUNOLOGY, 2004, 172 (07) :4470-4479
[3]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[4]   Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A(2) [J].
Bonventre, JV ;
Huang, ZH ;
Taheri, MR ;
OLeary, E ;
Li, E ;
Moskowitz, MA ;
Sapirstein, A .
NATURE, 1997, 390 (6660) :622-625
[5]   Cytosolic phospholipase A2α reigns supreme in arthritis and bone resorption [J].
Bonventre, JV .
TRENDS IN IMMUNOLOGY, 2004, 25 (03) :116-119
[6]   Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes [J].
Boyer, Jean Frederic ;
Balard, Patricia ;
Authier, Helene ;
Faucon, Bruno ;
Bernad, Jose ;
Mazieres, Bernard ;
Davignon, Jean-Luc ;
Cantagrel, Alain ;
Pipy, Bernard ;
Constantin, Arnaud .
ARTHRITIS RESEARCH & THERAPY, 2007, 9 (02)
[7]   Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis [J].
Boyer, Jean-Frederic ;
Gourraud, Pierre-Antoine ;
Cantagrel, Alain ;
Davignon, Jean-Luc ;
Constantin, Arnaud .
JOINT BONE SPINE, 2011, 78 (02) :179-183
[8]   The importance of T cell interactions with macrophages in rheumatoid cytokine production [J].
Brennan, FM ;
Foey, AD ;
Feldmann, M .
CURRENT CONCEPTS IN AUTOIMMUNITY AND CHRONIC INFLAMATION, 2006, 305 :177-194
[9]  
BRENNAN FM, 1989, LANCET, V2, P244
[10]   Targeting of Gr-l+,CCR2+ monocytes in collagen-induced arthritis [J].
Bruehl, Hilke ;
Cihak, Josef ;
Plachy, Jiri ;
Kunz-Schughart, Leoni ;
Niedermeier, Marianne ;
Denzel, Andrea ;
Gomez, Manuel Rodriguez ;
Talke, Yvonne ;
Luckow, Bruno ;
Stangassinger, Manfred ;
Mack, Matthias .
ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2975-2985